Search Results - Hovav Nechushtan

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    A New Role for the STAT3 Inhibitor, PIAS3

    A New Role for the STAT3 Inhibitor, PIAS3 by Carmit Levy, Hovav Nechushtan, Ehud Razin

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner

    Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner by Hovav Nechushtan, Nissim Benvenisty, Ruth Brandeis, Lea Reshef

    Published 1987
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral renal obstruction

    An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral renal obstruction by Rosenberg, Shilo, Katz, Ran, Pode, Dov, Gofrit, N. Ofer, Pizov, Galina, Hovav, Nechushtan

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas

    Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas by Kristopher A. Sarosiek, Raquel Malumbres, Hovav Nechushtan, Andrew J. Gentles, Eli Avisar, Izidore S. Lossos

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Suppression of Microphthalmia Transcriptional Activity by Its Association with Protein Kinase C-interacting Protein 1 in Mast Cells

    Suppression of Microphthalmia Transcriptional Activity by Its Association with Protein Kinase C-interacting Protein 1 in Mast Cells by Ehud Razin, Zhao Cheng Zhang, Hovav Nechushtan, Shahar Frenkel, Yu Nee Lee, Ramachandran Arudchandran, Juan Rivera

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas

    Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas by Xiaoqing Lu, Hovav Nechushtan, Feiying Ding, Manuel F. Rosado, Rakesh Singal, Ash A. Alizadeh, Izidore S. Lossos

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

    A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer by Hovav Nechushtan, Yousef Hamamreh, Nidal Salim, Maya Gotfried, Amichai Baron, Yossi Israeli Shalev, Benjjamin Nisman, Tamar Peretz, Nili Peylan‐Ramu

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Mitochondrial STAT3 plays a major role in IgE-antigen–mediated mast cell exocytosis

    Mitochondrial STAT3 plays a major role in IgE-antigen–mediated mast cell exocytosis by Tal Hadad Erlich, Zohar Yagil, Gillian Kay, Alona Peretz, Helena Migalovich-Sheikhet, Sagi Tshori, Hovav Nechushtan, Francesca Levi‐Schaffer, Ann Saada, Ehud Razin

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    LysRS Serves as a Key Signaling Molecule in the Immune Response by Regulating Gene Expression

    LysRS Serves as a Key Signaling Molecule in the Immune Response by Regulating Gene Expression by Nurit Yannay-Cohen, Irit Carmi-Levy, Gillian Kay, Christopher Maolin Yang, Jung Min Han, D.M. Kemeny, Sung‐Hoon Kim, Hovav Nechushtan, Ehud Razin

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

    Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study by Sara M. Tolaney, Hovav Nechushtan, Ilan-Gil Ron, Patrick Schöffski, Ahmad Awada, Chris Yasenchak, A. Douglas Laird, Bridget O’Keeffe, Geoffrey I. Shapiro, Eric P. Winer

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data

    Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world da... by Elizabeth Dudnik, Mor Moskovitz, Yakir Rottenberg, Anastasiya Lobachov, Rinat Mandelboim, Tzippy Shochat, Damien Urban, Mira Wollner, Hovav Nechushtan, Ofer Rotem, Alona Zer, Sameh Daher, Jair Bar

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program

    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program by Solange Peters, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, Jin‐Yuan Shih, Wei‐Yu Liao, Oliver Gautschi, Vito Spataro, Mojca Unk, James Chih‐Hsin Yang, Robert M. Lorence, Philippe Carrière, A. Cseh, Gee‐Chen Chang

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Structural Switch of Lysyl-tRNA Synthetase between Translation and Transcription

    Structural Switch of Lysyl-tRNA Synthetase between Translation and Transcription by Yifat Ofir‐Birin, Pengfei Fang, Steven Bennett, Huimin Zhang, Jing Wang, Inbal Rachmin, Ryan Shapiro, Jing Song, Arie Dagan, Jorge del Pozo, Sung‐Hoon Kim, Alan G. Marshall, Paul Schimmel, Xiang‐Lei Yang, Hovav Nechushtan, Ehud Razin, Min Guo

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

    BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors by Elizabeth Dudnik, Nir Peled, Hovav Nechushtan, Mira Wollner, Amir Onn, Abed Agbarya, Mor Moskovitz, S. Keren, Noa Popovits‐Hadari, Damien Urban, Moshe Mishaeli, Alona Zer, Aaron M. Allen, Natalie Maimon Rabinovich, Ofer Rotem, Teodor Kuznetsov, Tzippy Shochat, Laila C. Roisman, Jair Bar

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

    Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies by Doron Lipson, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A. Curran, Sohail Balasubramanian, Troy Bloom, Kristina Brennan, Amy Donahue, Sean R. Downing, Garrett M. Frampton, Lázaro Ibrahim Romero García, Frank Juhn, Kathy C Mitchell, Emily White, Jared White, Zac Zwirko, Tamar Peretz, Hovav Nechushtan, Lior Soussan‐Gutman, Young Tae Kim, Hidefumi Sasaki, Hyeong Ryul Kim, Seung-Il Park, Dalia Ercan, Christine E. Sheehan, Jeffrey S. Ross, Maureen Cronin, Pasi A. Jänne, Philip J. Stephens

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer

    Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer by Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner‐Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz‐Amit, Iris Kamer, Alona Zer, Mor Moskovitz, Adva Levy‐Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, T. Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P. Dicker, David P. Carbone, David R. Gandara

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

    A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer by Vladimir Lazar, Eitan Rubin, Stéphane Depil, Yudi Pawitan, Jean‐François Martini, Jesús Gómez-Navarro, Antoine Yver, Zhengyin Kan, Jonathan R. Dry, Jeanne Kehren, Pierre Validire, Jordi Rodón, Philippe Vielh, Michel Ducreux, Susan Galbraith, M. Lehnert, Amir Onn, Raanan Berger, Marco A. Pierotti, Angel Porgador, C.S. Pramesh, Dingwei Ye, André Lopes Carvalho, Gerald Batist, Thierry Le Chevalier, Philippe Morice, Benjamin Besse, Gilles Vassal, Andrew Mortlock, Johan Hansson, Ioana Berindan‐Neagoe, Robert Dann, Joel Haspel, Alexandru Irimie, Steve Laderman, Hovav Nechushtan, Amal Al‐Omari, Trent Haywood, Catherine Bresson, Khee Chee Soo, Iman Osman, Hilario Mata, J. Jack Lee, Komal Jhaveri, Guillaume Meurice, Gary A. Palmer, Ludovic Lacroix, Serge Koscielny, Karina Eterovic, Jean‐Yves Blay, Richard E. Buller, Alexander Eggermont, Richard L. Schilsky, John Mendelsohn, Jean‐Charles Soria, Mace L. Rothenberg, Jean–Yves Scoazec, Waun Ki Hong, Razelle Kurzrock

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers

    PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers by Alexander Drilon, Geoffrey R. Oxnard, Lori J. Wirth, Benjamin Besse, Oliver Gautschi, Sichuang Tan, Herbert H. Loong, Todd M. Bauer, Yoon Jun Kim, Atsushi Horiike, K. Park, Manisha H. Shah, Caroline E. McCoach, Lyudmila Bazhenova, Takeshi Seto, Marcia S. Brose, Nathan A. Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Y. Ohe, Karen L. Reckamp, Valentina Boni, Miyako Satouchi, Gerald S. Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D. Patel, Nehal J. Lakhani, Fabrice Barlési, Mark E. Burkard, Viola W. Zhu, Víctor Moreno, Jacques Médioni, Marc Matrana, Christian Rolfo, D.H. Lee, Hovav Nechushtan, Melissa L. Johnson, Vamsidhar Velcheti, Matomo Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lixin Song, Junyi Han, Alexander I. Spira, Filippo de Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara, S. Waqar, Hirotsugu Kenmotsu, F. Perry Wilson, Bijay Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Y. Zhu, Mai Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, S. Michael Rothenberg, Benjamin Solomon, Ken Goto, Vivek Subbiah

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

    Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunot... by Benjamin Besse, Enriqueta Felip, Rosario García Campelo, Manuel Cobo, Céline Mascaux, Anne Madroszyk, Federico Cappuzzo, Werner Hilgers, Gianpiero Romano, Fabrice Denis, Santiago Viteri, D. Debieuvre, Domenico Galetta, Editta Baldini, M. Razaq, G. Robinet, Michele Maio, Angelo Delmonte, Benoît Roch, Patrick Masson, Wolfgang Schuette, Alona Zer, Jordi Remón, D Costantini, B. Vasseur, Rafał Dziadziuszko, Giuseppe Giaccone, Milada Zemanová, Benjamin Besse, Clément Bonnet, Jacques Cadranel, C. Chouaïd, Alexis B. Cortot, D. Debieuvre, B. Delclaux, Fabrice Denis, Boris Duchemann, Claude El Kouri, François‐Régis Ferrand, M. Ginoux, Werner Hilgers, Anne Madroszyk, Patrick Masson, Julien Mazières, O. Molinier, Denis Moro‐Sibilot, Éric Pichon, Céline Mascaux, G. Robinet, Benoît Roch, Gérard Zalcman, Gerlinde Schmidtke-Schrezenmeier, Wolfgang Schuette, László Urbán, Maya Gottfried, Hovav Nechushtan, Nir Peled, M. Wollner, Alona Zer, Editta Baldini, Laura Bonanno, Andrea Bonetti, Federico Cappuzzo, Angelo Delmonte, Domenico Galetta, Michele Maio, V. Minotti, Antonio Rea, Gianpiero Romano, Davide Tassinari, Giuseppe Tonini, Rafał Dziadziuszko, Bogusława Karaszewska, Aleksandra Szczésna, Manuel Cobo, Javier de Castro, Enriqueta Felip, M.R. García Campelo, Ainhoa Hernández, Teresa Morán, Mariano Provencio, Santiago Viteri, Abhijit Dasgupta, Nashat Gabrail, Giuseppe Giaccone, A. Harshad, Stephen V. Liu, D. Oubre, Rajiv Panikkar, M. Razaq, Rachel E. Sanborn

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

    Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study by Luis Paz‐Ares, Óscar Juan, Giannis Mountzios, Enriqueta Felip, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M. Patel, Takayuki Takahama, Scott Owen, Douglas Reznick, Firas Badin, İrfan Çiçin, Sabeen Mekan, Riddhi Patel, Éric Zhang, Divyadeep Karumanchi, Marina Chiara Garassino, Elizabeth Ahern, Venessa Chin, Stephen Della‐Fiorentina, Kevin Jasas, Christos S. Karapetis, Jeremy Long, Louise Nott, Kenneth J. O’Byrne, Craig Underhill, Richard Greil, Maximilian J. Hochmair, Andreas Pircher, Wim Demey, Paul Germonpré, Elke Govaerts, Thierry Pieters, Reinier Wener, Alan A. Azambuja, Giuliano Santos Borges, Gilberto de Castro, Suellen Castro, Felipe Melo Cruz, Fábio Franke, Eduardo Silva, Parneet Cheema, Robert H. El-Maraghi, Swati Kulkarni, Rami Nassabein, Scott Owen, Clarisse Audigier-Valette, Jaafar Bennouna, C. Chouaïd, Alexis B. Cortot, S. Couraud, D. Debieuvre, Fabrice Denis, Patrick Dumont, Radj Gervais, Nicolas Girard, Etienne Giroux‐Leprieur, Florian Guisier, Sandrine Hiret, Henri Janicot, Corinne Lamour, J. Madelaine, M. Marcq, E. Pluquet, Jean Louis Pujol, Magali Ravoire, Marielle Sabatini, A. Vergnenègre, Sabine Bohnet, Martin Faehling, Melanie Janning, Eckart Laack, Niels Reinmuth, Achim Rittmeyer, Claas Wesseler, Sofia Baka, George Fountzilas, Panagiotis Katsaounis, Athanasios Κotsakis, Ioannis Mountzios, Konstantinos Syrigos, Julia Dudnik, Fink Carmel, Ofer Merimsky, Hovav Nechushtan, Julia Sobolev, Franceso Agustoni, Anna Bettini, Matteo Brighenti, Giulio Cerea, Filippo de Marinis, Salvatore Grisanti, Francesco Grossi, Andrea Luciani, Evaristo Maiello, Héctor Soto Parrà, Pierfrancesco Tassone, Giuseppe Tonini, Yoko Agemi

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: